0001209191-19-013742.txt : 20190226
0001209191-19-013742.hdr.sgml : 20190226
20190226182416
ACCESSION NUMBER: 0001209191-19-013742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190223
FILED AS OF DATE: 20190226
DATE AS OF CHANGE: 20190226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kopczynski Casey C.
CENTRAL INDEX KEY: 0001590001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 19634990
MAIL ADDRESS:
STREET 1: 135 U.S. HIGHWAY 206
STREET 2: SUITE 15
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-23
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001590001
Kopczynski Casey C.
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
0
1
0
0
Chief Scientific Officer
Common Stock
2019-02-23
4
F
0
328
40.04
D
102714
D
Common Stock
2019-02-24
4
F
0
669
40.04
D
102045
D
Common Stock
2019-02-25
4
F
0
534
40.18
D
101511
D
Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.
/s/ John LaRocca, Attorney-in-Fact for Casey C. Kopczynski
2019-02-26